伟思医疗
(688580)
| 流通市值：42.49亿 | | | 总市值：42.49亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 95,912,701.63 | 400,058,923.31 | 291,757,867.37 | 191,578,926.4 |
| 营业收入 | 95,912,701.63 | 400,058,923.31 | 291,757,867.37 | 191,578,926.4 |
| 二、营业总成本 | 66,399,984.17 | 324,845,883.81 | 231,830,532.26 | 154,659,278.69 |
| 营业成本 | 31,984,614.54 | 138,226,444.43 | 84,368,036.05 | 56,299,944.17 |
| 税金及附加 | 1,411,588.66 | 5,531,255.12 | 3,972,320.64 | 2,635,903.41 |
| 销售费用 | 14,856,454.13 | 94,371,066.87 | 78,091,594.75 | 50,300,484.1 |
| 管理费用 | 9,530,691.39 | 44,548,847.18 | 33,635,402.69 | 24,142,713.93 |
| 研发费用 | 9,664,611.61 | 50,613,388.74 | 39,929,327.9 | 28,731,566.97 |
| 财务费用 | -1,047,976.16 | -8,445,118.53 | -8,166,149.77 | -7,451,333.89 |
| 其中:利息费用 | 351,255.24 | 1,308,733.32 | 965,574.45 | 643,716.3 |
| 其中:利息收入 | 1,402,873.76 | 9,772,871.34 | 9,146,676.08 | 8,113,856.31 |
| 加:公允价值变动收益 | - | 2,419,469.21 | - | - |
| 加:投资收益 | 3,126,773.51 | 11,336,994.51 | 8,238,504.93 | 5,003,107.97 |
| 资产处置收益 | -864.63 | 3,909.66 | 434.96 | 434.96 |
| 资产减值损失(新) | - | -29,234.54 | - | - |
| 信用减值损失(新) | -84,188.61 | -1,276,267.87 | -133,334.87 | -139,747.28 |
| 其他收益 | 4,487,673.76 | 23,835,345.51 | 16,327,300.68 | 11,074,992.37 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 37,042,111.49 | 111,503,255.98 | 84,360,240.81 | 52,858,435.73 |
| 加:营业外收入 | 4,560.1 | 1,846,339.35 | 143,811.99 | 118,008.57 |
| 减:营业外支出 | - | 70,832.72 | 28,529.64 | 28,529.64 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 37,046,671.59 | 113,278,762.61 | 84,475,523.16 | 52,947,914.66 |
| 减:所得税费用 | 3,826,596.54 | 11,309,532.07 | 6,309,246.81 | 3,327,508.5 |
| 六、净利润 | 33,220,075.05 | 101,969,230.54 | 78,166,276.35 | 49,620,406.16 |
| 持续经营净利润 | 33,220,075.05 | 101,969,230.54 | 78,166,276.35 | 49,620,406.16 |
| 归属于母公司股东的净利润 | 33,220,075.05 | 101,969,230.54 | 78,166,276.35 | 49,620,406.16 |
| (一)基本每股收益 | 0.35 | 1.07 | 0.82 | 0.52 |
| (二)稀释每股收益 | 0.35 | 1.07 | 0.82 | 0.52 |
| 九、综合收益总额 | 33,220,075.05 | 101,969,230.54 | 78,166,276.35 | 49,620,406.16 |
| 归属于母公司股东的综合收益总额 | 33,220,075.05 | 101,969,230.54 | 78,166,276.35 | 49,620,406.16 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-25 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |